Glaxo’s Avandia prescriptions slump after study
Thursday, May 31st, 2007Reuters: LONDON - Doctors in the United States have shunned GlaxoSmithKline Plc’s diabetes drug Avandia since a study was published last week linking the drug to heart-attack risk, according to daily prescription data. Read More About Diabetes…